Where can I listen to this podcast?

This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

GEICAM T-Habla

Claim This Podcast

by Geicam

24 episodes

Updated Weekly

Accepts GuestsHas SponsorsLocation 🇪🇸

Podcast Overview

Un espacio con información sencilla y rigurosa sobre el cáncer de mama.

Language

🇪🇸

Publishing Since

7/15/2020

Visit Website View on Apple Podcasts RSS Feed

1 verified contact email on file for GEICAM T-Habla

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

See contact details

Recent Episodes

October 1, 2024

Avances en cáncer de mama presentados en el congreso ASCO 2024

Hablamos con el Dra. Cristina Hernando, oncóloga en el Hospital Clínico Universitario de Valencia e investigadora de GEICAM. Nos contará las novedades más relevantes presentadas durante la última edición del congreso de la Sociedad Estadounidense de Oncología Clínica, ASCO, fecha clave en la investigación del cáncer que tuvo lugar del 31 de mayo al 4 de junio.

June 3, 2024

Avances en cáncer de mama presentados en el congreso ESMO Breast 2024

Hablamos con el Dr. Alfonso López de Sá, oncólogo en el Hospital Clínico San Carlos de Madrid e investigador de GEICAM. Nos cuenta las novedades más relevantes presentadas durante la última edición del congreso que la Sociedad Europea de Oncología Médica, ESMO, dedica anualmente al cáncer de mama y que tuvo lugar del 15 al 17 de mayo en Berlín.

December 26, 2023

Avances en cáncer de mama presentados en el congreso San Antonio Breast Cancer Symposium (SABCS23)

Bienvenidos a una nueva entrega de GEICAM T-Habla, espacio dedicado a conversar con especialistas sobre diferentes temáticas relacionadas con el cáncer de mama. Hoy hablamos con la Dra. Begoña Bermejo, oncóloga en el Hospital Clínico Universitario de Valencia e investigadora de GEICAM. Nos contará las novedades más relevantes en cáncer de mama presentadas durante el congreso San Antonio Breast Cancer Symposium, cita clave en la investigación de esta enfermedad que este año tuvo lugar del 5 al 9 de diciembre en Texas.

24 total episodes available

Deep-dive analytics for GEICAM T-Habla

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is GEICAM T-Habla?: Un espacio con información sencilla y rigurosa sobre el cáncer de mama.
How often does this podcast release new episodes?: This podcast updates weekly.
Where can I listen to this podcast?: This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Does this podcast accept guests?: Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.